154 related articles for article (PubMed ID: 15969560)
1. Acylation versus sulfonylation in the inhibition of elastase by 3-oxo-beta-sultams.
Tsang WY; Ahmed N; Harding LP; Hemming K; Laws AP; Page MI
J Am Chem Soc; 2005 Jun; 127(25):8946-7. PubMed ID: 15969560
[TBL] [Abstract][Full Text] [Related]
2. Reactivity and selectivity in the inhibition of elastase by 3-oxo-beta-sultams and in their hydrolysis.
Tsang WY; Ahmed N; Hemming K; Page MI
Org Biomol Chem; 2007 Dec; 5(24):3993-4000. PubMed ID: 18043805
[TBL] [Abstract][Full Text] [Related]
3. Different transition-state structures for the reactions of beta-lactams and analogous beta-sultams with serine beta-lactamases.
Tsang WY; Ahmed N; Hinchliffe PS; Wood JM; Harding LP; Laws AP; Page MI
J Am Chem Soc; 2005 Dec; 127(49):17556-64. PubMed ID: 16332108
[TBL] [Abstract][Full Text] [Related]
4. Beta-sultams-mechanism of reactions and use as inhibitors of serine proteases.
Page MI
Acc Chem Res; 2004 May; 37(5):297-303. PubMed ID: 15147170
[TBL] [Abstract][Full Text] [Related]
5. Novel mechanism of inhibiting beta-lactamases by sulfonylation using beta-sultams.
Page MI; Hinchliffe PS; Wood JM; Harding LP; Laws AP
Bioorg Med Chem Lett; 2003 Dec; 13(24):4489-92. PubMed ID: 14643353
[TBL] [Abstract][Full Text] [Related]
6. Azetidine-2,4-diones (4-oxo-beta-lactams) as scaffolds for designing elastase inhibitors.
Mulchande J; Guedes RC; Tsang WY; Page MI; Moreira R; Iley J
J Med Chem; 2008 Mar; 51(6):1783-90. PubMed ID: 18290604
[TBL] [Abstract][Full Text] [Related]
7. Structure-reactivity relationships in the inactivation of elastase by beta-sultams.
Hinchliffe PS; Wood JM; Davis AM; Austin RP; Beckett RP; Page MI
Org Biomol Chem; 2003 Jan; 1(1):67-80. PubMed ID: 12929392
[TBL] [Abstract][Full Text] [Related]
8. An activated sulfonylating agent that undergoes general base-catalyzed hydrolysis by amines in preference to aminolysis.
Tsang WY; Ahmed N; Hemming K; Page MI
J Org Chem; 2008 Jun; 73(12):4504-12. PubMed ID: 18479166
[TBL] [Abstract][Full Text] [Related]
9. 3-Oxo-β-sultam as a Sulfonylating Chemotype for Inhibition of Serine Hydrolases and Activity-Based Protein Profiling.
Carvalho LAR; Almeida VT; Brito JA; Lum KM; Oliveira TF; Guedes RC; Gonçalves LM; Lucas SD; Cravatt BF; Archer M; Moreira R
ACS Chem Biol; 2020 Apr; 15(4):878-883. PubMed ID: 32176480
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of bacterial DD-peptidase by beta-sultams.
Llinás A; Ahmed N; Cordaro M; Laws AP; Frère JM; Delmarcelle M; Silvaggi NR; Kelly JA; Page MI
Biochemistry; 2005 May; 44(21):7738-46. PubMed ID: 15909988
[TBL] [Abstract][Full Text] [Related]
11. Acyl vs sulfonyl transfer in N-acyl beta-sultams and 3-oxo-beta-sultams.
Ahmed N; Tsang WY; Page MI
Org Lett; 2004 Jan; 6(2):201-3. PubMed ID: 14723528
[TBL] [Abstract][Full Text] [Related]
12. Catalytic asymmetric synthesis of beta-sultams as precursors for taurine derivatives.
Zajac M; Peters R
Chemistry; 2009 Aug; 15(33):8204-22. PubMed ID: 19609984
[TBL] [Abstract][Full Text] [Related]
13. 4-Oxo-beta-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase.
Mulchande J; Oliveira R; Carrasco M; Gouveia L; Guedes RC; Iley J; Moreira R
J Med Chem; 2010 Jan; 53(1):241-53. PubMed ID: 19904934
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of elastase by N-sulfonylaryl beta-lactams: anatomy of a stable acyl-enzyme complex.
Wilmouth RC; Westwood NJ; Anderson K; Brownlee W; Claridge TD; Clifton IJ; Pritchard GJ; Aplin RT; Schofield CJ
Biochemistry; 1998 Dec; 37(50):17506-13. PubMed ID: 9860865
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights into the inhibition of serine proteases by monocyclic lactams.
Wilmouth RC; Kassamally S; Westwood NJ; Sheppard RJ; Claridge TD; Aplin RT; Wright PA; Pritchard GJ; Schofield CJ
Biochemistry; 1999 Jun; 38(25):7989-98. PubMed ID: 10387042
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, stability, biochemical and pharmacokinetic properties of a new potent and selective 4-oxo-β-lactam inhibitor of human leukocyte elastase.
Mulchande J; Simões SI; Gaspar MM; Eleutério CV; Oliveira R; Cruz ME; Moreira R; Iley J
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):169-75. PubMed ID: 20545486
[TBL] [Abstract][Full Text] [Related]
17. Catalytic asymmetric formation of beta-sultams.
Zajac M; Peters R
Org Lett; 2007 May; 9(10):2007-10. PubMed ID: 17447778
[TBL] [Abstract][Full Text] [Related]
18. 7-alkylidenecephalosporin esters as inhibitors of human leukocyte elastase.
Buynak JD; Rao AS; Ford GP; Carver C; Adam G; Geng B; Bachmann B; Shobassy S; Lackey S
J Med Chem; 1997 Oct; 40(21):3423-33. PubMed ID: 9341917
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inactivation of human leukocyte elastase via an enzyme-induced sulfonamide fragmentation process.
Wei L; Lai Z; Gan X; Alliston KR; Zhong J; Epp JB; Tu J; Perera AB; Van Stipdonk M; Groutas WC
Arch Biochem Biophys; 2004 Sep; 429(1):60-70. PubMed ID: 15288810
[TBL] [Abstract][Full Text] [Related]
20. Computational study of pharmacophores: beta-sultams.
Barwick M; Abu-Izneid T; Novak I
J Phys Chem A; 2008 Oct; 112(43):10993-7. PubMed ID: 18828576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
